In trading on Wednesday, shares of Synageva BioPharma Corp (GEVA) crossed below their 200 day moving average of $49.95, changing hands as low as $49.43 per share. Synageva BioPharma Corp shares are currently trading off about 4.4% on the day. The chart below shows the one year performance of GEVA shares, versus its 200 day moving average:Looking at the chart above, GEVA's low point in its 52 week range is $34.01 per share, with $58.00 as the 52 week high point — that compares with a last trade of $49.41. According to the ETF Finder at ETF Channel, GEVA makes up 1.23% of the SPDR S&P Biotech ETF ( XBI) which is trading lower by about 1.2% on the day Wednesday.
More from Stocks
Stocks Higher as Investors Look to Jerome Powell for Hints on Fed Policy
Stocks are rising Thursday with investors looking to guidance from Fed Chairman Jerome Powell, who is scheduled to speak Friday.
Nordstrom's Mixed Earnings -- What Wall Street Is Saying
Nordstrom's discounting is concerning some analysts, while others question how long the retailer can cut costs.
Toro's Stock Jumps as Lawnmower Maker Beats Earnings Estimates
The CEO attributes a big jump in quarterly sales to the company's acquisition of Charles Machine Works, a maker of underground construction equipment.
Going Shopping? Jim Cramer Breaks Down Nordstrom's Quarter, Oil and Markets
Jim Cramer weighs in on Nordstrom's quarter, his latest thoughts on oil and the markets.
Retrophin Tanks After Neurological Treatment Fails Late-Stage Study
The treatment, fosmetpantotenate, fails to meet its primary endpoint when compared to a control group being treated with a placebo, the company says.